COVID-19 and Mortality in the Global Surgical Population: A Systematic Review and Meta-Analysis
Covid19-Sources
Long COVID-19 Symptom Profile in Children and Adolescents Tested for SARS-CoV-2
COVID tied to higher risk of inflammatory autoimmune diseases for 1 year
Long COVID-19 Symptom Profile in Children and Adolescents Tested for SARS-CoV-2
Pneumococcal vaccines may protect against viral respiratory infections, study finds
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Mortality, life expectancy, and population
High excess deaths in Sweden during the first wave of COVID-19: Policy deficiencies or ‘dry tinder’?
Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept study
Accelerated brain age in young to early middle-aged adults after mild to moderate COVID-19 infection
Background for CDC's Updated Respiratory Virus Guidance | Respiratory Illnesses | CDC
Prospective Memory Assessment before and after Covid-19 | NEJM
Cognition and Memory after Covid-19 in a Large Community Sample | NEJM
Was SARS-CoV-2 dem Körper antut: Eine wachsende und unvollständige Übersicht
Is ‘Long Covid’ similar to ‘Long SARS’?
Why Are We Still Flu-ifying COVID?
Coronavirus: few vaccines prevent infection – here’s why that’s not a problem
Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
ConclusionsCOVID-19 infection, including long-COVID, is associated with increased short- and long-term risks of CVD and mortality. Ongoing monitoring of signs and symptoms of developing these cardiovascular complications post diagnosis and up till at least a year post recovery may benefit infected patients, especially those with severe disease.
Covid 19 examining the effectiveness of non pharmaceutical interventions executive summary
Long-Covid-Cocktail: Ist das der Durchbruch?
Persistierende Infektionen mit SARS-CoV-2 sind nicht ungewöhnlich
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
Tissue Factor and COVID-19 Associated Thrombosis
Solving the puzzle of Long Covid
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
Audiovestibular adverse events following COVID-19 vaccinations
Clinical development of antivirals against SARS-CoV-2 and its variants
COVID-19 antiviral treatment should be taken for longer, says study